Utility of dietary phytoestrogens in preventing postmenopausal osteoporosis

Current Topics in Nutraceutical Research

Volumn 3, Issue 1, 2005, Pages 15-28

  Chiechi, Luigi Mario ^a,b   Micheli, Loredana ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NONE   (Italy)

Author keywords

Menopause; Osteoporosis; Phytoestrogens; Prevention

Indexed keywords

ALENDRONIC ACID; BIOCHANIN A; CALCITONIN; CALCIUM; COUMESTROL; DAIDZEIN; DAIDZIN; ENTERODIOL; ENTEROLACTONE; EQUOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETIDRONIC ACID; FORMONONETIN; GENISTEIN; GENISTIN; IPRIFLAVONE; ISOFLAVONE; LIGNAN; MATAIRESINOL; PARATHYROID HORMONE; PHYTOESTROGEN; PLACEBO; RALOXIFENE; RISEDRONIC ACID; SECOISOLARICIRESINOL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNINDEXED DRUG;

ALFALFA; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERALIZATION; BREAST CANCER; CARDIOVASCULAR DISEASE; CEREAL; CLINICAL TRIAL; CLOVER; DEMENTIA; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; EPIDEMIOLOGICAL DATA; FEEDING BEHAVIOR; FEMALE; FRUIT; GRAIN; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; INCIDENCE; INHIBITION KINETICS; LIFESTYLE; LINSEED; MEDITERRANEAN DIET; MENOPAUSAL SYNDROME; META ANALYSIS; NONHUMAN; OSTEOCLAST; PATIENT CARE; PEANUT; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RYE; SOCIAL PROBLEM; SOYBEAN; SUNFLOWER; SYSTEMATIC REVIEW; VEGETABLE; WALNUT;

ANIMALIA;

EID: 14944371196     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Adlercreutz H. (2002) Phytoestrogens and Cancer. Lancet Oncology 3, 364-373.
2. Adlercreutz H. (1999) Phytoestrogens. State of the art. Environmental Toxicology and Pharmacology 7, 201-207.
3. Adlercreutz H. Markkanen H, Watanabe S. (1993) Plasma concentrations of phytoestrogens in Japanese men. Lancet 342, 1209-1210.
4. Adlercreutz H. (1998) Evolution, nutrition, intestinal microflora, and prevention of cancer, a hypothesis. Proceedings of the Society for Experimental Biology and Medicine 217, 241-246.
5. Adlercreutz H, Hamalainen E, Gorbach S, Goldin B. (1992) Dietary phytoestrogens and the menopause in Japan. Lancet 339 1233.
6. Albertazzi P, Purdie DW. (2002) The nature and utility of the phytoestrogens, a review of the evidence. Maturitas 42, 173-185.
7. Alekel DL, Germain AS, Peterson CT, Hanson KB, Steward JW, Toda T. (2000) lsoflavone-rich protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. American Journal of Clinical Nutrition 72, 844-852.
8. Anderson JB, Chen XW, Garner SC. (2000) Effects of genistein on MT3T3-E1, an osteoblast-like cell in relation to expression of estrogen receptors and during cell differentiation. Journal of Nutrition 130, 666S-667S.
9. Arjmandi BH, Getunger MJ, Goyal NV, Alekel L, Hasler CM, Juna S, Drum ML, Hollis BW, Kukreja SC. (1998) The role of soy protein with normal or reduced isoflavones content in reversing ovarian hormone deficiency induced bone loss in rats. American Journal of Clinical Nutrition 68, 1358S-1363S.
10. Arjmandi BH, Alekel L, Hollis BW. (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. Journal of Nutrition 126, 161-167.
11. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Lowik CW, Pols HA, van Leeuwen JP. (1997) Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138,5067-5070.
12. Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA. (2004) The effects of phytoestrogen isoflavones on bone density in women, a double-blind, randomised, placebo-controlled trial. American Journal of Clinical Nutrition 79, 326-333.
13. Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KDR. (1982) The identification of the weak oestrogen equol [7-hydroxy-3-(4′-Hydroxyphenyl) chroman] in human urine. Biochemical Journal 201, 353-357.
14. Baron YM, Brincat M, Galea R, Baron AM. (1994) The epidemiology of osteoporotic fractures in Mediterranean Country. Calcified Tissue International 54, 365-369.
15. Blair HC, Jordan SE, Peterson TG, Barnes S. (1996) Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. Journal of Cellular Biochemestry 61, 629-637.
16. Blank RD, Bockman RS. (1999) A review of clinical trials of therapies for osteoporosis using fracture as an end point. Journal of Clinical Densitometry 2, 435-452.
17. Boonen S, Lesaffre E, Dequeker J, Aerssens J, Nijs J, Pelemans W, Bouillon R. (1996) Relationship between baseline IGF-I and femoral bone density in women aged over 70 years, potential implications for prevention of age-related bone loss. Journal of American Geriatric Society 44, 1301-1306.
18. Branca F. (2003) Dietary phytoestrogens and bone health. Proceedings of Nutritional Society 62, 877-887.
19. Brandi ML. (1993) New treatment strategies, ipriflavone, strontium, vitamin D metabolites and analogs. American Journal Medicine 95, 69S.
20. Brouns F, Vermeer C. 2002 Functional food ingredients for reducing the risks of osteoporosis. Trends in Food Science & Technology 11, 22-33.
21. Brzezinski A, Debi A. (1999) Phytoestrogens, the "natural" selective estrogen receptor modulators? European Journal of Obstetrics and Gynecology Reproduction Biology 85, 47-51.
22. Bryant Hu, Glasebrook AL, Yang NN, Sato M. (1999) An estrogen receptor basis for raloxifene action in bone. Journal of Steroid Biochemestry and molecular Biology 69, 37-44.
23. Cai DJ, Cullen DM, Turner CH, Weaver CM. (2002) Conparative effects of Soy Isoflavones, Soy Protein and 17 beta-Estradiol on Calcium and Bone Metabolism in Adult Ovariectomized rats. Journal of Nutrition 132, 581S-582S.
24. Carusi D. (2000) Phytoestrogens as hormone replacement therapy, an evidence-based approach. Obstetrics and Gynecology 7 253-259.
25. Cassidy A, Bingham S, Setchell. K. (1994) Biological effects of a diet of soy protein rich isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition 60, 333-340.
26. Chen Z, Zheng W, Custer LJ. (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutition and Cancer 33, 82-87.
27. Chen YM, Ho SC, Lam SSH, Ho SSS, Woo JLF. (2003) Soy isoflavones have a favourable effect on bone loss in Chinese postmenopausal women with lower bone mass, a double-blind, randomised, controlled trial. Journal of Clinical Endocrinology and Metabolism 88, 4740- 4747.
28. Chiechi L.M., Secreto G, Vimercati A, Greco P, Venturelli E, Pansini F, Fanelli M, Loizzi P, Selvaggi L. (2002) The effects of a soy rich diet on serum lipids, the Menfis randomized trial. Maturitas 41, 97-104.
29. Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P. (2002) Efficacy of a soy rich diet in preventing postmenopausal osteoporosis. The Menfis randomized trial. Maturitas 42, 295-300.
30. Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. (2001) Soybean ethanol extarc increases the function of osteoblastic MC3T3-E1 cells. Phytochemistry 56, 733-739.
31. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery M-L, Moreton T. (2001) The effect of isoflavones extracted from red lover-Rimostil- on lipid and bone metabolism. Menopause 8, 259-265.
32. Cooper C, Campion G, Melton LJD. (1992) Hip fractures in the elderly, a world-wide projection. Osteoporosis International 2 285-289.
33. Cornwell T. Cohick W, Raskin I. (2004) Dietary phytoestrogens and health. Phytochemistry 65, 995-1016.
34. Coxam V. (2003) Prevention of osteopenia by phytooestrogens, animal studies. British Journal of Nutrition 89(1S), S75-85.
35. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJ. (1998) Effects of dietary phytoestrogens in postmenopausal women. Climateric 1, 124-129.
36. Dalais FS, Ebelling PR, Kotsopulos D, McGrath BP, Teede HJ. (2003) The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clinical Endocrinology 58, 704-709.
37. 2, osteoblast-like activity. Annual of Nutrition and Metabolism 45, 228 (abstract).
38. Dang ZC, Papapoulos S, Lowik C. (2002) Phytoestrogens enhance osteogenesis and concurrently inhibit adipogenesis. Journal of Nutrition 132, 617S (abstract).
39. Day AJ, DuPont MS, Ridley S, Rhodes M, Rhodes MJ, Morgan MR, Williamson G. (1998) Deglycosylation of flavonoid and isoflavonoid glucosides by human small intestine and liver betaglucosidase activity. FEBS Letters 436, 71-75.
40. De KleiJn MG, Nan der Shouw YT, Wilson PW (2001). Intake of dietary phytoestrogens in postmenopausal women is low in the United States, The Framngham study. Journal of Nutrition 131, 1826-1832.
41. Delmas PD, Fraser M. (1998) European Union Challenges Member States to fight the "Silent Epidemic" of osteoporosis. Eurohealth 4, 1-4.
42. Di Leo, Tarolo GL, Bestetti A, Tagliabue L, Delsole A, Aliberti G, Cestaio B, Pepe L. (2000) Osteoporosi e fitoestrogeni, valutazione della densità minerale ossea mediante tomografia computerizzata quantitativa periferica nelle donne lattoovovegetariane nella premenopausa. Radiologia Medica Torino 99, 250-257.
43. Dixon RA, Ferreira D. (2002) Genistein. Phytochemistry 60, 205-211.
44. Dragsted LO, Strube M, Larsen JC. (1993) Cancer-protective factors in fruits and vegetables, biochemical and biological background. Pharmacology and Toxicology 72(S), 116-135.
45. Ernst M, Heath JK, Schmid C, Froesch RE, Rodan GA. (1989) Evidence for direct effect of estrogen on bone cells in vitro. Journal of Steroid Biochemistry 34, 279-284.
46. Fitzpatrick LA. (2003) Soy isoflavones, hope or hype? Maturitas 1S, S21-S29.
47. Fukui Y, Miura A, Nara Y, Uesugi T, Yamori H, Yamori Y. (2000) Relationship between urinay isoflavones and bone metabolism in postmenopausal Japanese women. Journal of Nutrition 130, 686S.
48. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. (2004) The effect of soy protein on bone and lipid metabolism. Menopause 11 290-298.
49. Gambacciani M, Spinetti A, Piaggesi L, Cappagli B, Taponeco F, Manetti P, Weiss C, Teti GC. (1994) La Commare P, Facchini V. Ipriflavone prevents the bone mass reduction in premenopausal women treated with Gonadotropin Hormone-Releasing Hormone Agonists. Bone And Mineral 26, 19-26.
50. Grady D, Herrington D, Bitner V for the HERS Research Group. (2002) Cardiovascular disease outcome during 6.8 years of hormone therapy. Heart and Estrogen/progestin Replacement Study follow up (HERS II). Journal of American Medical Association 288, 49-57.
51. Greendale GA, Fitzgerald G, Huang MH, Sternfeld B, Gold E, Seeman T, Sherman S, Sowers M. (2002) Dietary soy isoflavones and bone mineral density, results from study of Women's Health across the Nation. American Journal of Epidemiology 155, 746-754.
52. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. (2002) Production and action of estrogens. English Journal of Medicine 346, 340-352.
53. Ham KD, Carlson CS. (2004) Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. Journal of Bone and Mineral Research 19, 823-829.
54. Ho SC. (2001) Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. Journal of Bone and Mineral Research 16, 1363-1369.
55. Holmberg L, Anderson H; HABITS steering and data monitoring committee. (2004) HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomized comparison, trial stopped. Lancet 363, 453-454.
56. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. (2000) Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporosis 11, 721-724.
57. Hsu CS, Shen WW, Hsueh YM, Yeh SL. (2001) Soy isoflavone supplemention in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. Journal of Reproduction Medicine 46, 221-226.
58. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-Beta. Natural Medicine 2, 1132-1136.
59. Hulley S, Furberg C, Carret-Connor E. (2002) For the Hers Research group. Noncardiovascular disease outcome during 6.8 years of hormone therapy. Heart and Estrogen/progestin Replacement Study follow-up. Journal of American Medical Association 288, 58-66.
60. Kajia J, Okabe K, Okamoto F, Tsuzuki T, Soeda H. (2000) Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts. Journal of Cellular Physiology 183, 83-90.
61. Kameda T, Mano H, Yuasa T. Mori Y, Miyazawa K, Shiodawa M, Nakamaru. Y, Hiroi E, Hiura K, Kameda A, Yan NN, Hakeda Y, Kumegawa M. (1997) Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. Journal of Experimental Medicine 186, 489-495.
62. Kanis JA. (1995) Treatment of osteoporosis in erderly women. American Journal of Medicine S2A, 60-66.
63. Kao YC, Zhou CB, Sherman M, Laughton CA, Chen S. (1998) Molecular basis of the inhibition of human aromatase estrogen synthase by flavone and isoflavone phytoestrogens - a site-directed mutagenesis study. Environmental Health Perspectives 106, 85-92.
64. Kao PC, P'eng FK. (1995) How to reduce the risk factors of osteoporosis in Asia. Zhonghua Yi, Xue Za Zhi 55, 209-213.
65. Knight DC, Eden JA. (1996) A review of the clinical effects of phytoestrogens. Obstetrics and Gynecology 87, 897-904.
66. Knuckles BE, Defremery D, Kohler GO. (1976) Coumestrol content of fractions obtained during wet processing of alfalfa. Journal of Agricultural Food Chemistry 24, 1177-1180.
67. Kreijkamp-Kaspers S, Kok L, Grobbes DE, De Haan EH, Aleman A, Lampe JW, Van Der Schouw YT. (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women, a randomized controlled trial. Journal of American Medical Association 292, 65-74.
68. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263.
69. Kurzer MS, XU X. (1997) Dietary phytoestrogens. Annual Review of Nutrition 132, 570S-573S.
70. Kurzer MS, XU X. (1997) Dietary phytoestrogens. Annual Review of Nutrition 17, 353S-358S.
71. Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge D, Schatzkin A, Schairer C. (2002) Menopausal hormone replacement therapy and the risk of ovarian cancer. Journal of American Medical Association 288, 334-341.
72. Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Goldberg. (1997) Hip fractures incidence among elderly Asian-American populations. American Journal of Epidemiology 146, 502-509.
73. Lee YB, Lee HJ, Kim KS, Lee JY, Nam SY, Cheon SH, Sohn HS. (2004) Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Bioscience, Biotechnology and Biochemistry 68, 1040-1045.
74. Lindsay R, Hart DM, Aitken JM, MacDonald ED, Anderson JB, Clarke AC. (1976) Long term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1, 1038-1041.
75. Lindsay R, Hart DM, MacLeah A, Clarke AG, Kraszewiski A, Garwood J. (1978) Bone response to termination of oestrogen treatment. Lancet 1, 1325-1327.
76. Lu L-JW, Anderson KE, Grady JJ, Nagamani M. (2002) Chronic soy consumption infuences serum levels of steroid and peptide hormones without uterine effects in postmenopausal women. Journal of Nutrition 132, 615S.
77. Lydeking-Olsen E, Jensen J- BE, Setchell. KDR, Damhus M, Jensen TH. (2002) Isoflavone-rich soymilk prevents bone-loss in the lumbar spine of postmenopausal women, a 2 year study. Journal of Nutrition 132, 582S.
78. Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T. (2004) Soymilk or progesterone for prevention of bone loss. A 2 year randomised, placebo-controlled trial. European Journal of Nutrition 43, 246-257.
79. Mei J, Yeung SSC, Kung AWC. (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. Journal of Clinical Endocrinology and Metabolism 86, 5217-5221.
80. Miksicek RJ. (1995) Estrogenic flavonoids, structural requirements for biological activity. Proceedings of the Society for Experimental Biology and Medicine 208, 44-50.
81. Million Women Study (MWS) Collaborators. (2003) Breast Cancer and Hormone-Replacement Therapy in the Million Women Study. Lancet 362, 419-427.
82. Morabito N, Crisaffilli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women, a randomized double-blind placebo-controlled study. Journal of Bone and Mineral Research 17, 1904-1912.
83. Nikander E, Metsa-Heikkila M, Ylikorkala O, Tiitinen A. (2004) Effects of phytoestrogens on bone turnover in postmenopausal women with to history of breast cancer. Journal of Clinical Endocrinology and Metabolism 89, 1207-1212.
84. Nilsson M, Aman P, Harkonen H, Bach Knudsen KE, Mazur W, Adlercreutz; H. (1997) Content of nutrients and lignans in roller milled fractions of rye. Journal of Science of Food Agriculture 73, 143-148.
85. [No authors listed]. (2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement. National Institutes of Health, USA 17,1-45.
86. [No Authors]. (2000) The role of isoflavones in menopausal health, Consensus Opinion of the North American Menopause Society. Menopause 7, 215-229.
87. Okamoto F, Okabe K, Kajiya H. (2001) Genistein, a soybean isoflavone, inhibits inward rectifier K+ channels in rat osteoclasts. Japanese Journal of Physiology 51, 501-509.
88. Omi N, Aoi S, Murata K, Ezawa I. (1994) Evaluation of the effect of soybean milk and soybean milk peptides on bone metabolism in the rat model with ovariectomized osteoporosis. Journal of Nutritional Science Vitaminol-Tokyo-40, 201-211.
89. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. (1997) Expression of estrogen receptor in rat bone. Endocrinology 138 4509-4512.
90. Ososki A, Kennelly EJ. (2003) Phytoestrogens, a review of the Present State of Research. Phytotherapy Research 17, 845-869.
91. Pacifici R. (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. Journal of Bone and Mineral Research 11,1043-1051.
92. Pansini F, Bonaccorsi G, Albertazzi P. (1997) Soy phytoestrogens and bone. Proceedings of the North American Menopause Society 44 (abst).
93. Parkin DM. Cancers of breast, endometrium and ovary, geographic correlations. (1989) European Journal of Cancer and Clinical Oncology 25, 1917-1925.
94. Pienta KJ, Goodson JA, Esper PS. (1996) Epidemiology of prostate cancer, molecular and enciromental clues. Urology 48 676-683.
95. Pike AC, Brzozowski AM, Hubbard Re. (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO Journal 18 4680-4689.
96. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. (1998) Soy protein and isoflavones, Their effects on blood lipids and bone density in postmenopausal women. American Journal of Clinical Nutrition 68, 1375S-1379S.
97. Raffaelli B, Hoikkala A, Leppala E, Wahala K. (2002) Enterolignans. Journal of Chromatography B 777, 29-43.
98. Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Cournot G. (2001) Daidzein inhibits osteoclast differenziation and activity in vito. Annual of Nutrition and Metabolism 45, 230 (abstract).
99. Reinli K, Block G. (1996) Phytoestrogen content of foods - to compendium of literature values. Nutrition and Cancer 26, 123-148.
100. Scheiber M, Liu J, Subbiah M, Reabar R, Setchell KDR. (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disesase in normal postmenopausal women. Menopause 8, 384-392.
101. Seeman E, Karlsson MK, Duan Y. (2000) On exposure to anorexia nervosa, the temporal variation in axial and appendicular skeletal development predisposes to site-specific deficits in bone size and density, a cross-sectional study. Journal of Bone and Mineral Research 5, 2259-2265.
102. Setchell K, Lydeking-Olsen E. (2003) Dietary phytoestrogens and their effect on bone, evidence from in vitro and in vivo, human observational, and dietary intervention studies. American Journal of Clinical Nutrition 78(S), 593S-609S.
103. Setchell KD, Lawson AM, Borriello SP, Harkness R, Gordon H, Morgan DM, Kirk DN, Adlercreutz H, Anderson LC, Axelson M. (1981) Lignan formation in man microbial involvement and possible roles in relation to cancer. Lancet 2, 4-7.
104. Setchell KDR, Bron NB, Lydeking-Olsen E. (2002) The clinical significance of the metabolite equol, a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 132, 3577-3584.
105. Setchell KDR, Brown NB, Zimmer- Nechemias L. (2002) Evidence for lack of absorption of soy isoflavone glycoside in humans, supporting the crucial role of intestinal metabolism for bioavailability. American Journal of Clinical Nutrition 76, 447-453.
106. Shemesh M, Lindner HR, Aylon N. (1972) Affinity of rabbit uterine oestradiol receptor for phytoestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. Journal of Reproduction and Fertility 29, 1-9.
107. Simonet WS, Lacey DL, Dunstan CR. (1997) Osteoprotegerin, a novel secreted protein involved in the regulation of bone density. Cell 89, 309-310.
108. Slavin JL, Karr SC, Hutchins AM, Lampe JW. (1998) Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. American Journal of Clinical Nutrition 69, 1492S-1495S.
109. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K. (1997) Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. Journal of Bone and Mineral Research 12, 1272-1276.
110. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. (2001) Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology 97, 109-115.
111. Song YS, Paik Hy. (2002) Soybean intake and bone mineral density change in Korean college women. Epidemiological observations. Journal of Nutrition 132, 616S.
112. Sung CJ, Choi SH, Ko B-S. (2000) Urinary isoflavone levels and several factors that influence bone metabolism in postmenopausal women. Journal of Nutrition 130, 685S.
113. Spence LA, Lipscomb ER, Cadogan J, Martin BR, Peacock M, Weaver CM. (2002) Effects of Soy Isoflavones on Calcium Metabolism in Postmenopausal Women. Journal of Nutrition 132, 581S.
114. Steinmetz KA, Potter JD. (1991) Vegetables, fruit, and cancer. I Epidemiology. Cancer Cause Control 2, 325-357.
115. Steinmetz KA, Potter JD. (1991) Vegetables, fruit, and cancer. II Mechanisms. Cancer Cause Control 2, 427-442.
116. Teramoto T, Sakamoto A,Toda T, Okuhira T, Koketsu I. (2002) Effects of ingesting a beverage containing soy isoflavones on urinary bone resorption markers. Journal of Nutrition 132, 614S.
117. Thompson LU, Richard SE, Cheung F. (1997) Variability in anticancer lignan levels in flaxseed. Nutrition and Cancer 27 26-30.
118. Thompson LU, Robb P, Serraino M, Cheung F. (1991) Mammalian lignan production from various foods. Nutrition and Cancer 16 43-52.
119. Tsutsumi N. (1995) Effect of coumestrol on bone metabolism in organ culture. Biological and Pharmaceutical Bullettin 18, 1012-1015.
120. Unfer V, Casini MI, Costabile L, Mignosa M, Gerli S, Di Renzo GC. (2004) Endometrial effects of long-term treatment with phytoestrogens, a randomized, double-blind, placebo-controlled study. Fertility and Sterility 82, 145-148.
121. Valtuena S, Cashman K, Robins SO, Cassidy A, Kardinal A, Branca F. (2003) Investigating the role of natural phytoestrogens on bone health in postmenopausal women. British Journal of Nutrition 89 (1S), S87-S99.
122. Visentin P, Ciravegna R, Fabris F. (1997) Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy. Maturitas 26, 185-192.
123. Vitolins M, Anthony M, Lenschik L, Bland DR, Burke GL. (2002) Does soy protein and its isoflavones prevent bone loss in peri- and post-menopausal women? Results of a 2 year randomized clinical trial. Journal of Nutrition 132, 582S.
124. Wakal K, Egami I, Kato K. (1999) Dietary intake and sources of isoflavones among Japanase. Nutrition and Cancer 33, 139-145.
125. Walace WA. (1983) The increasing incidence of fractures of the proximal femur, an orthopaedic epidemic. Lancet 1, 1413-1414.
126. Wang L-Q. (2002) Mammalian phytoestrogens, entrodiol and enterolactone. Journal of Chromatography B 777, 289-309.
127. Wang HJ, Murphy PA. (1994) Isoflavone content in commercial soybean foods. Journal of Agricultural Chemistry 42, 1666-1673.
128. Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer MS. (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. Journal of Clinical Endocrinology and Metabolism 85, 3043-3049.
129. Wong WW. (2000) Effects of soy isoflavones on blood lipids, blood pressure and biochemical markers of bone metabolism in postmenopausal women. Journal of Nutrition 130, 686S.
130. Writing Group for the Women's Health Iniziative Investigators. (2002) Risk and benefits of estrogen plus progestin in healthy postmenopausal women, principal results from the Women's Health Initiative randomized controlled trial. Journal of American Medical Association 228, 321-333.
131. Yamaguchi M, Sugimoto E. (2000) Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells, activation of aminoacyl-t-RNA synthetase. Molecular and Cellular Biochemestry 214, 97-102
132. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW. Wu Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF. (1993) Migration pattern and breast cancer risk in Asian-American women. Journal of the National Cancer Institute 85, 1819-1827.